These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 7890061)
41. [Expression of HOXA10 gene in human endometrium and its relationship with unexplained infertility]. Li H; Chen S; Xing F Zhonghua Fu Chan Ke Za Zhi; 2002 Jan; 37(1):30-2. PubMed ID: 11953062 [TBL] [Abstract][Full Text] [Related]
42. Differential expression of interleukins (IL) IL-13 and IL-15 throughout the menstrual cycle in endometrium of normal fertile women and women with recurrent spontaneous abortion. Chegini N; Ma C; Roberts M; Williams RS; Ripps BA J Reprod Immunol; 2002; 56(1-2):93-110. PubMed ID: 12106886 [TBL] [Abstract][Full Text] [Related]
43. Interleukin-18 system messenger RNA and protein expression in human endometrium during the menstrual cycle. Huang HY; Chan SH; Yu HT; Wang HS; Lai CH; Soong YK Fertil Steril; 2006 Oct; 86(4):905-13. PubMed ID: 17027359 [TBL] [Abstract][Full Text] [Related]
44. P-glycoprotein expression is increased in human secretory and gestational endometrium. Axiotis CA; Guarch R; Merino MJ; Laporte N; Neumann RD Lab Invest; 1991 Nov; 65(5):577-81. PubMed ID: 1721668 [TBL] [Abstract][Full Text] [Related]
45. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy. Bourdrez P; Bongers MY; Mol BW Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006 [TBL] [Abstract][Full Text] [Related]
46. Ultrastructural signs of an interference in the carbohydrate metabolism of human endometrium produced by the intrauterine copper-T device. Nilsson O; Hagenfeldt K; Johannisson E Acta Obstet Gynecol Scand; 1974; 53(2):139-49. PubMed ID: 4822346 [TBL] [Abstract][Full Text] [Related]
47. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Wildemeersch D; Schacht E Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454 [TBL] [Abstract][Full Text] [Related]
48. Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors. Rutanen EM; Nyman T; Lehtovirta P; Ammälä M; Pekonen F Int J Cancer; 1994 Nov; 59(3):307-12. PubMed ID: 7523316 [TBL] [Abstract][Full Text] [Related]
49. Serum and endometrial copper, zinc, iron and cobalt with inert and copper-containing IUCDs. Fahmy K; Ghoneim M; Eisa I; el-Gazar A; Afifi A Contraception; 1993 May; 47(5):483-90. PubMed ID: 8513675 [TBL] [Abstract][Full Text] [Related]
50. [Expression of ER and PR in the endometrium of patients with intrauterine adhesions]. Gan L; Duan H; Wang S; Xu Q; Tang YQ Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):47-52. PubMed ID: 28190315 [No Abstract] [Full Text] [Related]
51. Expression of alpha4beta1 and alphavbeta3 integrins in the endometrium of women using the T200 copper intrauterine device. Savaris R; Zettler CG; Ferrari AN Fertil Steril; 2000 Dec; 74(6):1102-7. PubMed ID: 11119734 [TBL] [Abstract][Full Text] [Related]
52. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium. Burton KA; Henderson TA; Hillier SG; Mason JI; Habib F; Brenner RM; Critchley HO Hum Reprod; 2003 Dec; 18(12):2610-7. PubMed ID: 14645180 [TBL] [Abstract][Full Text] [Related]
53. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908 [TBL] [Abstract][Full Text] [Related]
54. Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle. O'Reilly G; Charnock-Jones DS; Davenport AP; Cameron IT; Smith SK J Clin Endocrinol Metab; 1992 Dec; 75(6):1545-9. PubMed ID: 1464662 [TBL] [Abstract][Full Text] [Related]
55. Abnormal pattern of integrin expression at the implantation window in endometrium from fertile women treated with clomiphene citrate and users of intrauterine device. Gonzalez RR; Palomino A; Vantman D; Gabler F; Devoto L Early Pregnancy (Cherry Hill); 2001 Apr; 5(2):132-43. PubMed ID: 11753526 [TBL] [Abstract][Full Text] [Related]
56. [The effect of intrauterine contraceptive devices on the endometrium]. Sheppard BL; Bonnar J Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565 [TBL] [Abstract][Full Text] [Related]
57. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone. Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525 [TBL] [Abstract][Full Text] [Related]
59. Expression of basic fibroblast growth factor and its mRNA in uterine endometrium during the menstrual cycle. Fujimoto J; Hori M; Ichigo S; Tamaya T Gynecol Endocrinol; 1996 Jun; 10(3):193-7. PubMed ID: 8862495 [TBL] [Abstract][Full Text] [Related]
60. Variant progesterone receptor mRNAs are co-expressed with the wild-type progesterone receptor mRNA in human endometrium during all phases of the menstrual cycle. Marshburn PB; Zhang J; Bahrani-Mostafavi Z; Matthews ML; White J; Hurst BS Mol Hum Reprod; 2005 Nov; 11(11):809-15. PubMed ID: 16339776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]